ENTITY

Ergomed (ERGO LN)

18
Analysis
Health Care • United Kingdom
Ergomed provides specialized services to the pharmaceutical and biotechnology industries, focusing on clinical development, trial management, and pharmacovigilance. The company operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV), offering solutions for all phases of clinical trials and post-approval drug safety. Ergomed was founded in 1997 and is headquartered in Guildford, United Kingdom.
more
bullish•Ergomed
•09 Aug 2026 11:48

Primer: Ergomed (ERGO LN) - Aug 2026

Privately Held with Strong Backing: Following its acquisition by private equity firm Permira in November 2023 for approximately £703.1 million,...

Logo
92 Views
Share
bullish•Eoflow
•15 Oct 2023 07:05

Last Week In Event SPACE: EOFlow, Fast Retailing, JMDC, Origin Energy

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
834 Views
Share
bullish•Ergomed
•09 Oct 2023 13:37

No Danger in Being Long

Spread turned negative and widened in the last week. I believe the risk/reward of adding at or below 1,340p is more favourable considering that...

Share
bullish•Ergomed
•17 Apr 2023 17:01•Issuer-paid

Ergomed - Solid FY22 marked by broad-based growth

Ergomed reported FY22 results broadly in line with our expectations. Group revenues grew 22.5% y-o-y to £145.3m, underpinned by sustained demand...

Share
bullish•Ergomed
•21 Dec 2022 20:12•Issuer-paid

Ergomed - Exiting FY22 on a strong footing

In the run-up to Ergomed’s FY22 trading update (expected end-January 2023), we take a fresh look at our estimates for the company and make minor...

Share
x